Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.155
-0.003 (-2.08%)
At close: Nov 22, 2024, 4:00 PM
0.159
+0.004 (2.84%)
After-hours: Nov 22, 2024, 7:22 PM EST
Applied DNA Sciences Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 10.44 | 7.15 | 15.22 | 6.55 | 7.79 | 0.56 | Upgrade
|
Cash & Short-Term Investments | 10.44 | 7.15 | 15.22 | 6.55 | 7.79 | 0.56 | Upgrade
|
Cash Growth | -2.92% | -53.00% | 132.12% | -15.82% | 1293.01% | -66.32% | Upgrade
|
Receivables | 0.51 | 0.26 | 3.07 | 2.8 | 0.19 | 0.84 | Upgrade
|
Inventory | 0.47 | 0.33 | 0.6 | 1.37 | 0.5 | 0.14 | Upgrade
|
Prepaid Expenses | 0.42 | 0.39 | 1.06 | 0.57 | 0.6 | 0.6 | Upgrade
|
Total Current Assets | 11.84 | 8.13 | 19.94 | 11.3 | 9.08 | 2.15 | Upgrade
|
Property, Plant & Equipment | 1.4 | 2.08 | 2.22 | 3.02 | 1.28 | 0.23 | Upgrade
|
Goodwill | - | - | - | - | 0.29 | 0.29 | Upgrade
|
Other Intangible Assets | 2.7 | 2.7 | - | - | 0.61 | 0.73 | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | - | 0.11 | Upgrade
|
Other Long-Term Assets | 0.75 | 0.75 | 0.1 | 0.1 | 0.1 | 0.06 | Upgrade
|
Total Assets | 16.69 | 13.65 | 22.27 | 14.42 | 11.34 | 3.56 | Upgrade
|
Accounts Payable | 1.6 | 1.07 | 1.74 | 2.01 | 1.25 | 1.15 | Upgrade
|
Accrued Expenses | 0.84 | 1.2 | 1.88 | 0.98 | 0.68 | 0.46 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 1.83 | - | Upgrade
|
Current Portion of Leases | 0.53 | 0.5 | - | - | - | - | Upgrade
|
Current Unearned Revenue | 0.05 | 0.08 | 0.56 | 0.28 | 0.51 | 0.63 | Upgrade
|
Total Current Liabilities | 3.03 | 2.85 | 4.19 | 3.27 | 4.27 | 2.25 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.52 | 1.55 | Upgrade
|
Long-Term Leases | 0.33 | 0.74 | - | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 0.19 | 0.19 | - | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.68 | 0.68 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.22 | 4.32 | 5.17 | 0.03 | 0.85 | 0.62 | Upgrade
|
Total Liabilities | 4.46 | 8.78 | 9.36 | 3.3 | 5.63 | 4.41 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
Additional Paid-In Capital | 318.76 | 307.38 | 305.4 | 295.23 | 275.55 | 255.96 | Upgrade
|
Retained Earnings | -306.38 | -302.45 | -292.5 | -284.12 | -269.84 | -256.81 | Upgrade
|
Total Common Equity | 12.39 | 4.95 | 12.91 | 11.11 | 5.72 | -0.84 | Upgrade
|
Minority Interest | -0.16 | -0.08 | -0 | -0 | -0.01 | -0.01 | Upgrade
|
Shareholders' Equity | 12.23 | 4.87 | 12.91 | 11.11 | 5.71 | -0.85 | Upgrade
|
Total Liabilities & Equity | 16.69 | 13.65 | 22.27 | 14.42 | 11.34 | 3.56 | Upgrade
|
Total Debt | 0.87 | 1.24 | - | - | 2.35 | 1.55 | Upgrade
|
Net Cash (Debt) | 9.57 | 5.91 | 15.22 | 6.55 | 5.44 | -0.99 | Upgrade
|
Net Cash Growth | 1.84% | -61.13% | 132.12% | 20.48% | - | - | Upgrade
|
Net Cash Per Share | 6.21 | 9.05 | 33.93 | 18.95 | 27.77 | -21.40 | Upgrade
|
Filing Date Shares Outstanding | 10.3 | 0.68 | 0.65 | 0.37 | 0.28 | 0.17 | Upgrade
|
Total Common Shares Outstanding | 10.3 | 0.68 | 0.65 | 0.37 | 0.26 | 0.06 | Upgrade
|
Working Capital | 8.82 | 5.28 | 15.76 | 8.03 | 4.81 | -0.1 | Upgrade
|
Book Value Per Share | 1.20 | 7.25 | 20.01 | 29.69 | 22.24 | -14.02 | Upgrade
|
Tangible Book Value | 9.69 | 2.25 | 12.91 | 11.11 | 4.83 | -1.86 | Upgrade
|
Tangible Book Value Per Share | 0.94 | 3.30 | 20.01 | 29.69 | 18.77 | -31.02 | Upgrade
|
Machinery | - | 4.13 | 4.17 | 3.67 | 3.2 | 2.23 | Upgrade
|
Leasehold Improvements | - | 0.12 | 0.12 | 0.12 | 0.52 | 0.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.